BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28276780)

  • 1. Utility of registries for post-marketing evaluation of medicines. A survey of Swedish health care quality registries from a regulatory perspective.
    Feltelius N; Gedeborg R; Holm L; Zethelius B
    Ups J Med Sci; 2017 Jun; 122(2):136-147. PubMed ID: 28276780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Registries: An Underused Resource for Medicines Evaluation : Operational proposals for increasing the use of patient registries in regulatory assessments.
    McGettigan P; Alonso Olmo C; Plueschke K; Castillon M; Nogueras Zondag D; Bahri P; Kurz X; Mol PGM
    Drug Saf; 2019 Nov; 42(11):1343-1351. PubMed ID: 31302896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pragmatic clinical trials in the context of regulation of medicines.
    Gedeborg R; Cline C; Zethelius B; Salmonson T
    Ups J Med Sci; 2019 Jan; 124(1):37-41. PubMed ID: 30251577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Registries in European post-marketing surveillance: a retrospective analysis of centrally approved products, 2005-2013.
    Bouvy JC; Blake K; Slattery J; De Bruin ML; Arlett P; Kurz X
    Pharmacoepidemiol Drug Saf; 2017 Dec; 26(12):1442-1450. PubMed ID: 28345151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of 103 Swedish Healthcare Quality Registries.
    Emilsson L; Lindahl B; Köster M; Lambe M; Ludvigsson JF
    J Intern Med; 2015 Jan; 277(1):94-136. PubMed ID: 25174800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year comprehensive medical management of degenerative lumbar spine disease (lumbar spondylolisthesis, stenosis, or disc herniation): a value analysis of cost, pain, disability, and quality of life: clinical article.
    Parker SL; Godil SS; Mendenhall SK; Zuckerman SL; Shau DN; McGirt MJ
    J Neurosurg Spine; 2014 Aug; 21(2):143-9. PubMed ID: 24785973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Registry-Based Medical Research: Data Dredging or Value Building to Quality of Care?
    Mulder DS; Spicer J
    Ann Thorac Surg; 2019 Jul; 108(1):274-282. PubMed ID: 30742816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A perspective for the role of drug registries in the post-marketing surveillance].
    Traversa G; Sagliocca L; Magrini N; Venegoni M
    Recenti Prog Med; 2013 Jun; 104(6):280-7. PubMed ID: 23801234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports.
    Köhler M; Haag S; Biester K; Brockhaus AC; McGauran N; Grouven U; Kölsch H; Seay U; Hörn H; Moritz G; Staeck K; Wieseler B
    BMJ; 2015 Feb; 350():h796. PubMed ID: 25722024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug registries: post-marketing evaluation of the benefit-risk profile and promotion of appropriateness. The regional point of view].
    Martelli L; Venegoni M
    Recenti Prog Med; 2013 Jun; 104(6):272-4. PubMed ID: 23801232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Swedish guidelines for registry-based randomized clinical trials.
    Nyberg K; Hedman P
    Ups J Med Sci; 2019 Jan; 124(1):33-36. PubMed ID: 30724666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Policies to foster quality improvement registries: lessons from the Swedish case.
    Levay C
    J Intern Med; 2016 Feb; 279(2):160-72. PubMed ID: 26435356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilizing national and international registries to enhance pre-market medical device regulatory evaluation.
    Yue LQ; Campbell G; Lu N; Xu Y; Zuckerman B
    J Biopharm Stat; 2016; 26(6):1136-1145. PubMed ID: 27540636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new Swedish twin registry containing environmental and medical base line data from about 14,000 same-sexed pairs born 1926-58.
    Medlund P; Cederlöf R; Flodérus-Myrhed B; Friberg L; Sörensen S
    Acta Med Scand Suppl; 1976; 600():1-111. PubMed ID: 16995293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case-based information systems in Swedish health care. General aspects and experiences from the Stockholm County Council.
    Paulson EM
    Stud Health Technol Inform; 1994; 14():39-45. PubMed ID: 10163694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of drug registries in the post-marketing surveillance].
    Traversa G; Sagliocca L; Magrini N; Venegoni M
    Recenti Prog Med; 2013 Jun; 104(6):225-8. PubMed ID: 23801224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported outcomes 3 months after spine surgery: is it an accurate predictor of 12-month outcome in real-world registry platforms?
    Parker SL; Asher AL; Godil SS; Devin CJ; McGirt MJ
    Neurosurg Focus; 2015 Dec; 39(6):E17. PubMed ID: 26621415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.